SEQUENOM INC. NEW läuft weiter megamässsig!!
| eröffnet am: | 24.07.08 12:52 von: | buran |
| neuester Beitrag: | 25.04.21 03:54 von: | Jenniferqpata |
| Anzahl Beiträge: | 389 | |
| Leser gesamt: | 35248 | |
| davon Heute: | 3 | |
bewertet mit 3 Sternen |
||
|
|
||
13.12.14 15:20
#352
buran
Governance Documents
http://www.sequenom.com/invest/corporate-governance GrB
13.12.14 15:21
#353
buran
Satz mit X datt war'n Hosen WIX #51
Dschorannimo iss RAUS ..unddd BASTA ..ha
Kosmonova buran
Kosmonova buran
13.12.14 15:22
#354
buran
Communication with the Board of Directors
board@sequenom.com
http://www.sequenom.com/invest/corporate-governance
http://www.sequenom.com/invest/corporate-governance
13.12.14 15:23
#357
buran
ANALYST COVERAGE........ ::
http://www.sequenom.com/invest/analyst-coverage GrB
13.12.14 15:24
#358
buran
Price Data
http://www.sequenom.com/invest/stock-information GrB
13.12.14 15:25
#360
buran
Historical Price Lookup
http://www.sequenom.com/invest/stock-information GrB
13.12.14 15:26
#361
buran
Stock Chart
http://www.sequenom.com/invest/stock-information GrB
13.12.14 15:27
#363
buran
SEC FILINGS...... ::
http://www.sequenom.com/invest/sec-filings GrB
13.12.14 15:29
#365
buran
Annual Reports
http://www.sequenom.com/invest/financial-reports GrB
13.12.14 15:29
#366
buran
Quarterly Reports
http://www.sequenom.com/invest/financial-reports GrB
13.12.14 15:37
#369
buran
fundamentals
http://www.sequenom.com/invest/fundamentals GrB
13.12.14 15:38
#370
buran
press releases
http://www.sequenom.com/press GrB
13.12.14 15:40
#371
buran
boing boing boing boing boing
ILLUMINA AND SEQUENOM POOL NONINVASIVE PRENATAL TESTING INTELLECTUAL PROPERTY AND END OUTSTANDING PATENT DISPUTES http://www.sequenom.com/press/...esting-intellectual-property-and-end
13.12.14 15:42
#374
buran
Under the agreement, Illumina will have exclusive
worldwide rights to utilize the pooled intellectual property to develop and sell in-vitro diagnostic kits for NIPT and to license third-party laboratories wishing to develop and sell their own laboratory-developed NIPT tests under the collection of pooled patents. In addition, Sequenom and Illumina will each have rights to utilize all pooled patents to develop and sell their own respective laboratory-developed NIPT tests. The parties will share the revenue from the patent pool and Illumina will pay Sequenom a royalty on sales of in-vitro diagnostic kits for NIPT. http://www.sequenom.com/press/...esting-intellectual-property-and-end

